John Kraus Email & Phone Number

With over 25 years of experience in clinical, academic, pharmaceutical medicine, and drug development, John upholds Otsuka’s mission to create new products for better health worldwide. As Executive Vice President and Chief Medical Officer, John is responsible for steering the organization and progressing Otsuka’s pipeline from development through to commercialization. With a holistic approach to overcoming challenges, John places patients at the center and inspires impactful change. He is dedicated to addressing the gaps in treatment and advancing care for underserved patients. He has played a critical role in leading Otsuka’s CNS R&D efforts including design and oversight of all clinical research programs and protocols, due diligence of potential acquisitions, in-licensing or joint-development programs for clinical viability and prospective commercial success. Throughout his career, John has led, contributed to, or managed drug development programs across several psychiatric, neurological, immunoinflammatory and rare diseases, including schizophrenia, major depressive disorder, anxiety disorders, bipolar disorder, Duchenne muscular dystrophy, amyotrophic lateral sclerosis, myasthenia gravis, multiple sclerosis, epilepsy, Parkinson’s disease, Alzheimer’s disease, neuropathic pain, neuro injury, psoriasis and atopic dermatitis. John also has experience in substantial regulatory engagement, including with the Food and Drug Administration, Pharmaceutical and Medical Device Agency, European Medicines Agency and Paediatric Committee. In addition, John is a Diplomate, American Board of Psychiatry & Neurology, and a Distinguished Fellow of the American Psychiatric Association

Listed skills include Pharmaceutical Industry, Clinical Research, Drug Development, Clinical Trials, and 5 others.